Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-methods study evaluates the feasibility and acceptability of the Bridge to Belonging (B2B) intervention for older gay and bisexual men living with HIV. The program combines a CBT-based Friendship Enrichment Program, peer mentoring, and connection to elder services to foster social engagement. Participants are evaluated with qualitative and quantitative methods to understand how well the intervention can be implemented and accepted, and to explore potential effects on loneliness and depression. The trial is conducted at Fenway Health in Boston, with collaboration from the National Institute on Aging. It is not designed to test efficacy in this phase but to inform future work.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV+ and provide evidence or documentation of HIV+ status
* Willing to release HIV-related health records
* Self-identify as a man who has sex with men
* Able to provide informed consent in English
* Be ≥50 years old
* Score at least a 2 on the PHQ-2 OR score at least a 4 on the UCLA Shortened Loneliness Scale

Exclusion Criteria:

* HIV-
* Does not self-identify as a man who has sex with men
* Is less than 50 years old
* Scores less than 2 on the PHQ-2 AND scores less than 4 on the UCLA Shortened Loneliness Scale

Where it's running

• Fenway Health
  Boston, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: Abigail W Batchelder, PhD, MPH
• Email: abigail.batchelder@bmc.org
• Phone: 6173587640

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

• Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV

  This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.

  Recruiting Tourcoing Hospital · Tourcoing · NCT07745530

• Care Disengagement Prevention for People Living with HIV in Indonesia

  This intervention tests a stigma-reduction approach to help people living with HIV in Indonesia stay connected with HIV care.

  Recruiting University of California, Los Angeles · Depok, West Java · NCT07706634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.